Distinct Narcolepsy Syndromes in Orexin Receptor-2 and Orexin Null Mice Molecular Genetic Dissection of Non-REM and REM Sleep Regulatory Processes

[1]  M. I. Smith,et al.  Evidence implicating a role for orexin-1 receptor modulation of paradoxical sleep in the rat , 2003, Neuroscience Letters.

[2]  E. Mignot,et al.  Sleeping with the hypothalamus: emerging therapeutic targets for sleep disorders , 2002, Nature Neuroscience.

[3]  E. Mignot,et al.  The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. , 2002, Archives of neurology.

[4]  H. Ohtsu,et al.  Anatomical, Physiological, and Pharmacological Characteristics of Histidine Decarboxylase Knock-Out Mice: Evidence for the Role of Brain Histamine in Behavioral and Sleep–Wake Control , 2002, The Journal of Neuroscience.

[5]  Ming-Fung Wu,et al.  Release of Hypocretin (Orexin) during Waking and Sleep States , 2002, The Journal of Neuroscience.

[6]  J. Sutcliffe,et al.  The hypocretins: Setting the arousal threshold , 2002, Nature Reviews Neuroscience.

[7]  A. Yamatodani,et al.  The effect of orexin-A and -B on the histamine release in the anterior hypothalamus in rats , 2002, Neuroscience Letters.

[8]  Y. Inoue,et al.  CSF hypocretin‐1 (orexin‐A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia , 2002, Journal of sleep research.

[9]  A. Yamanaka,et al.  Orexins activate histaminergic neurons via the orexin 2 receptor. , 2002, Biochemical and biophysical research communications.

[10]  J. Yesavage,et al.  CSF hypocretin/orexin levels in narcolepsy and other neurological conditions , 2001, Neurology.

[11]  Thomas E. Scammell,et al.  The sleep switch: hypothalamic control of sleep and wakefulness , 2001, Trends in Neurosciences.

[12]  H. Haas,et al.  Orexin/Hypocretin Excites the Histaminergic Neurons of the Tuberomammillary Nucleus , 2001, The Journal of Neuroscience.

[13]  E. Mignot,et al.  Decreased brain histamine content in hypocretin/orexin receptor-2 mutated narcoleptic dogs , 2001, Neuroscience Letters.

[14]  M. Serafin,et al.  Orexins (hypocretins) directly excite tuberomammillary neurons , 2001, The European journal of neuroscience.

[15]  E. Mignot,et al.  Fluctuation of extracellular hypocretin‐1 (orexin A) levels in the rat in relation to the light–dark cycle and sleep–wake activities , 2001, European Journal of Neuroscience.

[16]  Y. Urade,et al.  Arousal effect of orexin A depends on activation of the histaminergic system , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[17]  R. Szymusiak,et al.  Brain structures and mechanisms involved in the generation of NREM sleep: focus on the preoptic hypothalamus. , 2001, Sleep medicine reviews.

[18]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[19]  C. Saper,et al.  Differential expression of orexin receptors 1 and 2 in the rat brain , 2001, The Journal of comparative neurology.

[20]  E. Mignot,et al.  Hypocretin Levels in Sporadic and Familial Cases of Canine Narcolepsy , 2001, Neurobiology of Disease.

[21]  Jon T. Willie,et al.  Genetic Ablation of Orexin Neurons in Mice Results in Narcolepsy, Hypophagia, and Obesity , 2001, Neuron.

[22]  Emmanuel Mignot,et al.  Hypocretin/orexin, sleep and narcolepsy , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.

[23]  R. Maki,et al.  Identification and functional analysis of mutations in the hypocretin (orexin) genes of narcoleptic canines. , 2001, Genome research.

[24]  R. Maki,et al.  Identification and Functional Analysis of Mutations in the Hypocretin (Orexin) Genes of Narcoleptic Canines , 2001, Genome Research.

[25]  I. Sora,et al.  Dopaminergic Role in Stimulant-Induced Wakefulness , 2001, The Journal of Neuroscience.

[26]  E. Mignot,et al.  Is narcolepsy a REM sleep disorder? Analysis of sleep abnormalities in narcoleptic Dobermans , 2000, Neuroscience Research.

[27]  Michael Aldrich,et al.  Reduced Number of Hypocretin Neurons in Human Narcolepsy , 2000, Neuron.

[28]  Sebastiaan Overeem,et al.  A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains , 2000, Nature Medicine.

[29]  C. Peyron,et al.  The hypocretin/orexin ligand–receptor system: implications for sleep and sleep disorders , 2000, Trends in Neurosciences.

[30]  J. Shneerson.  Handbook of Sleep Medicine , 2000 .

[31]  Emmanuel Mignot,et al.  The Sleep Disorder Canine Narcolepsy Is Caused by a Mutation in the Hypocretin (Orexin) Receptor 2 Gene , 1999, Cell.

[32]  Jon T. Willie,et al.  Narcolepsy in orexin Knockout Mice Molecular Genetics of Sleep Regulation , 1999, Cell.

[33]  M. Yanagisawa,et al.  Widespread distribution of orexin in rat brain and its regulation upon fasting. , 1999, Biochemical and biophysical research communications.

[34]  R D Ogilvie,et al.  EEG spectral analysis of the sleep-onset period in narcoleptics and normal sleepers. , 1999, Sleep.

[35]  G. Barsh,et al.  Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area , 1998, The Journal of comparative neurology.

[36]  A. N. van den Pol,et al.  Neurons Containing Hypocretin (Orexin) Project to Multiple Neuronal Systems , 1998, The Journal of Neuroscience.

[37]  C. Saper,et al.  Innervation of Histaminergic Tuberomammillary Neurons by GABAergic and Galaninergic Neurons in the Ventrolateral Preoptic Nucleus of the Rat , 1998, The Journal of Neuroscience.

[38]  S. Carr,et al.  Orexins and Orexin Receptors: A Family of Hypothalamic Neuropeptides and G Protein-Coupled Receptors that Regulate Feeding Behavior , 1998, Cell.

[39]  M. Aldrich.  Diagnostic aspects of narcolepsy , 1998, Neurology.

[40]  F E Bloom,et al.  The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[41]  K. Kitahama,et al.  Localization of candidate genomic regions influencing paradoxical sleep in mice , 1997, Neuroreport.

[42]  E. Mignot,et al.  PHARMACOLOGICAL ASPECTS OF HUMAN AND CANINE NARCOLEPSY , 1997, Progress in Neurobiology.

[43]  M. Dyken,et al.  Diagnosing narcolepsy through the simultaneous clinical and electrophysiologic analysis of cataplexy. , 1996, Archives of neurology.

[44]  M. Jouvet,et al.  Histaminergic descending inputs to the mesopontine tegmentum and their role in the control of cortical activation and wakefulness in the cat , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[45]  M. Dyken,et al.  Narcolepsy: Unequivocal diagnosis after split‐screen, video‐polysomnographic analysis of a prolonged cataplectic attack , 1994, Neurology.

[46]  M. Steriade,et al.  Brainstem Control of Wakefulness and Sleep , 1990, Springer US.

[47]  T. Juji,et al.  HLA in Narcolepsy , 1988, Springer Berlin Heidelberg.

[48]  A. Eschalier,et al.  Pharmacokinetic patterns of repeated administration of antidepressants in animals. I. Implications for antinociceptive action of clomipramine in mice. , 1988, The Journal of pharmacology and experimental therapeutics.

[49]  C. Kushida,et al.  Electroencephalographic correlates of cataplectic attacks in narcoleptic canines. , 1985, Electroencephalography and clinical neurophysiology.

[50]  M. Radulovački,et al.  Adenosine analogs and sleep in rats. , 1984, The Journal of pharmacology and experimental therapeutics.

[51]  M. Mitler,et al.  Canine model of narcolepsy: Genetic and developmental determinants , 1982, Experimental Neurology.

[52]  K. Kitahama,et al.  Instrumental and pharmacological paradoxical sleep deprivation in mice: Strain differences , 1980, Neuropharmacology.

[53]  E. A. Lucas,et al.  Sleep cycle organization in narcoleptic and normal dogs , 1979, Physiology & Behavior.

[54]  T. Roth,et al.  Narcolepsy and automatic behavior: a case report. , 1979, The Journal of clinical psychiatry.

[55]  M. Mitler,et al.  Sleep studies on canine narcolepsy: pattern and cycle comparisons between affected and normal dogs. , 1977, Electroencephalography and clinical neurophysiology.

[56]  Christian Guilleminault,et al.  Altered states of consciousness in disorders of daytime sleepiness , 1975, Journal of the Neurological Sciences.

[57]  C. Guilleminault,et al.  A study on cataplexy. , 1974, Archives of neurology.

[58]  B. Roth,et al.  REM sleep and NREM sleep in narcolepsy and hypersomnia. , 1969, Electroencephalography and clinical neurophysiology.

[59]  B. Roth,et al.  Pathophysiological mechanisms of narcolepsy, hypersomnia and dissociated sleep disturbances. , 1969, Electroencephalography and clinical neurophysiology.

[60]  W Dement,et al.  The nature of the narcoleptic sleep attack , 1966, Neurology.

[61]  C. Saper,et al.  Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons. , 2002, The Journal of clinical investigation.

[62]  Emmanuel Mignot,et al.  The role of hypocretins (orexins) in sleep regulation and narcolepsy. , 2002, Annual review of neuroscience.

[63]  Jon T. Willie,et al.  To eat or to sleep? Orexin in the regulation of feeding and wakefulness. , 2001, Annual review of neuroscience.

[64]  C. Koch,et al.  Neural Basis of Consciousness , 2001 .

[65]  Jones Be.  The neural basis of consciousness across the sleep-waking cycle. , 1998, Advances in neurology.

[66]  S. Carr,et al.  Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. , 1998, Cell.

[67]  Y. Hishikawa,et al.  Physiology of REM sleep, cataplexy, and sleep paralysis. , 1995, Advances in neurology.

[68]  Y. Honda.  Clinical Features of Narcolepsy: Japanese Experiences , 1988 .